Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data

Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data

Bibliographic Details
Main Author:	Thorsten Rudroff
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-10-01
Series:	Frontiers in Pharmacology
Subjects:	Multiple sclerosis Cannabis thc cbd neuropathic pain
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2019.01239/full

Similar Items

The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial
by: Julie Schjødtz Hansen, et al.
Published: (2021-09-01)

Cannabidiol to Improve Mobility in People with Multiple Sclerosis
by: Thorsten Rudroff, et al.
Published: (2018-03-01)

Cannabis and Multiple Sclerosis—The Way Forward
by: Thorsten Rudroff, et al.
Published: (2017-06-01)

Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial
by: Julie Schjødtz Hansen, et al.
Published: (2023-07-01)

"Medical cannabis" – compendium of pharmacist’s knowledge
by: Natalia Anna Piekuś-Słomka
Published: (2020-03-01)

Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends
by: Xintian Lyu, BS, et al.
Published: (2023-01-01)

Cannabis and cannabinoid medications for the treatment of chronic orofacial pain: A scoping review
by: Jory Longworth, et al.
Published: (2023-03-01)

Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
by: Raquel Maria P. Campos, et al.
Published: (2021-11-01)

Differentiating Cannabis Products: Drugs, Food, and Supplements
by: Arash Salehi, et al.
Published: (2022-06-01)

Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial
by: Sukpiriyagul A, et al.
Published: (2023-08-01)

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
by: Arun Bhaskar, et al.
Published: (2021-07-01)

Medical Cannabis in Children
by: Adi Aran, et al.
Published: (2020-01-01)

Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
by: Brishna S. Kamal, et al.
Published: (2018-10-01)

Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
by: Jamie Corroon, et al.
Published: (2019-12-01)

Phytocannabinoids and Cannabis-Based Products as Alternative Pharmacotherapy in Neurodegenerative Diseases: From Hypothesis to Clinical Practice
by: Yolanda Paes-Colli, et al.
Published: (2022-05-01)

Identification of Phenotypic Characteristics in Three Chemotype Categories in the Genus Cannabis
by: Dan Jin, et al.
Published: (2021-02-01)

A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics
by: Kevin P. Hill, et al.
Published: (2021-07-01)

Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
by: Jerome Sarris, et al.
Published: (2020-01-01)

Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
by: Lara Sharpe, et al.
Published: (2020-10-01)

Impact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis (Cannabis sativa L)
by: Nirit Bernstein, et al.
Published: (2019-06-01)

Oral Cannabis consumption and intraperitoneal THC:CBD dosing results in changes in brain and plasma neurochemicals and endocannabinoids in mice
by: Nichole Reisdorph, et al.
Published: (2024-03-01)

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
by: Erin L. Martin, et al.
Published: (2021-09-01)

Cannabis and Sleep: A Systematic Review of the Effects of Cannabinoids on Sleep Disorders
by: Anna Luchowska, et al.
Published: (2023-01-01)

Standardized Cannabis Smoke Extract Induces Inflammation in Human Lung Fibroblasts
by: Noof Aloufi, et al.
Published: (2022-03-01)

Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes
by: Hollis C. Karoly, et al.
Published: (2020-12-01)

A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
by: Überall MA
Published: (2020-02-01)

Cannabis sativa L.: A New Promising Crop for Medical and Industrial Use
by: Dimitrios BILALIS, et al.
Published: (2019-11-01)

Buds and Bugs: A Fascinating Tale of Gut Microbiota and Cannabis in the Fight against Cancer
by: Ahmad K. Al-Khazaleh, et al.
Published: (2024-01-01)

Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice
by: Leos Landa, et al.
Published: (2018-03-01)

Biological Activity of <i>Cannabis sativa</i> L. Extracts Critically Depends on Solvent Polarity and Decarboxylation
by: Guillermo Moreno-Sanz, et al.
Published: (2020-10-01)

A One-Step Grafting Methodology Can Adjust Stem Morphology and Increase THCA Yield in Medicinal Cannabis
by: Sarah Jane Purdy, et al.
Published: (2022-03-01)

Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry
by: Joshua D. Brown, et al.
Published: (2020-04-01)

Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain
by: Sherelle L. Casey, et al.
Published: (2018-07-01)

Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model
by: Sherelle L. Casey, et al.
Published: (2022-08-01)

Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots
by: Dan Jin, et al.
Published: (2021-07-01)

Autism and associated disorders: cannabis as a potential therapy
by: Mariana Babayeva, et al.
Published: (2022-01-01)

The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
by: Fatma Haddad, et al.
Published: (2022-05-01)

The use of cannabinoid compounds in therapy in children - future or threat?
by: Joanna Cieszkowska, et al.
Published: (2023-05-01)

Legal <i>Cannabis sativa</i> L. Dried Inflorescences: Cannabinoids Content and Cytotoxic Activity against Human HepG2 Cell Line
by: Maria Assunta Acquavia, et al.
Published: (2023-04-01)

Safety of Medical Cannabis in Neuropathic Chronic Pain Management
by: Alessandra Bennici, et al.
Published: (2021-10-01)